The EY Clinical Trial Fast Lane solution is designed to activate clinical trials in 45 to 60 working days through rapid performance of functional services, process excellence, deep understanding of clinical trial operations, real-time transparency across all involved stakeholders and prompt risk mitigation.
The EY Clinical Trial Fast Lane solution enabled Moores Cancer Center to accelerate activation of its highest priority clinical trials and implement related process improvements to improve clinical trial activation timelines across all clinical trials. As a result, MCC patients had access to these innovative, investigational treatments and therapies up to 11 times faster than traditional timelines for the institution.